| 2007 |
TMEM192 (encoded by LOC201931/FLJ38482) was identified as an integral lysosomal membrane protein by mass spectrometry-based proteomics of purified placental lysosomal membranes, and confirmed to localize to lysosomal organelles when expressed as a fluorescent fusion protein in HeLa cells. |
Organellar proteomics (mass spectrometry of purified lysosomal membranes) + fluorescent tag overexpression in HeLa cells |
Traffic (Copenhagen, Denmark) |
Medium |
17897319
|
| 2010 |
TMEM192 localizes to lysosomal/late endosomal membranes, possesses four transmembrane segments, is not N-glycosylated, and forms homodimers linked by interchain disulfide bridges, as shown by co-immunoprecipitation, Western blotting under reducing/non-reducing conditions, Percoll density gradient co-sedimentation with LAMP-2 and cathepsin D, and immunofluorescence co-localization with lysosomal markers. |
Co-immunoprecipitation, non-reducing SDS-PAGE/Western blot, Percoll density gradient centrifugation, immunofluorescence with lysosomal markers, antibody generation and validation |
Biological chemistry |
High |
20370317
|
| 2011 |
TMEM192 is targeted to late endosomes/lysosomes via two adjacent N-terminal dileucine motifs of the DXXLL-type; disruption of both motifs causes mistargeting to the plasma membrane, while each motif alone is sufficient for correct targeting. The C-terminal Cys266 residue forms the interchain disulfide bond responsible for TMEM192 homodimerization, and both N- and C-termini face the cytosol. |
CD4 chimeric construct mutagenesis, site-directed mutagenesis of dileucine motifs and cysteine residues, immunogold labeling, proteinase protection assay |
The Biochemical journal |
High |
21143193
|
| 2012 |
Knockdown of TMEM192 in HepG2 hepatoma cells induces autophagy (increased LC3-II) and subsequent apoptosis via the mitochondrial pathway; the apoptosis is blocked by silencing the autophagy gene ATG7, placing TMEM192 upstream of ATG7-dependent autophagy in this cell death pathway. |
siRNA knockdown, LC3-II Western blot, apoptosis assays, epistasis by ATG7 co-knockdown |
Oncology reports |
Medium |
22736246
|
| 2016 |
TMEM192 physically interacts with the tumor suppressor TIG1 (both TIG1A and TIG1B isoforms) at lysosomes, and is required for TIG1-mediated upregulation of autophagy (Beclin-1 and LC3-B induction); silencing TMEM192 reduces TIG1- and all-trans retinoic acid-induced autophagic activity. |
Yeast two-hybrid, co-immunoprecipitation, co-localization by fluorescence microscopy, siRNA knockdown with autophagy marker readout |
Molecules and cells |
Medium |
27989102
|
| 2017 |
TMEM192 is ubiquitinated by the SCF-FBXO27 E3 ubiquitin ligase complex upon lysosomal damage, identified in a screen for substrates of glycoprotein-directed ubiquitination during lysophagy. |
Ubiquitination screen upon lysosomal damage, FBXO27 overexpression, mass spectrometry identification of ubiquitinated substrates |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
28743755
|
| 2017 |
Murine TMEM192 resides in lysosomes, is ubiquitously expressed, undergoes tissue-specific proteolytic processing by pH-dependent lysosomal proteases to generate a 17 kDa fragment, and TMEM192-knockout MEFs display normal lysosomal morphology, autophagy, and lysosomal exocytosis under basal conditions. |
Immunofluorescence, Western blot, Percoll gradient, TMEM192-/- knockout mouse generation and analysis, histopathology, biochemical assays of autophagy and lysosomal exocytosis |
Oncotarget |
High |
28504966
|
| 2019 |
TMEM192 tagged with 3xHA on the lysosomal membrane enables highly efficient immunoprecipitation-based lysosome enrichment (LysoIP), outperforming density gradient and nanoparticle approaches with enrichment factors up to 118-fold for lysosomal proteins. |
Comparative organelle enrichment by immunoprecipitation of 3xHA-TMEM192, data-independent acquisition mass spectrometry, benchmarking against sucrose gradient and SPION methods |
Journal of proteome research |
High |
31738065
|
| 2024 |
Multiplexed DNA-PAINT super-resolution imaging using TMEM192 as a lysosomal marker revealed that TMEM192 marks a specific subpopulation of late endosomes/lysosomes, distinct from LAMP1/LAMP2-ubiquitous populations, identifying up to eight LEL subpopulations with unique protein compositions. |
Multiplexed DNA-PAINT super-resolution fluorescence imaging with quantitative single-organelle analysis |
The Journal of cell biology |
Medium |
39485275
|
| 2024 |
Endogenous TMEM192 can be immunoprecipitated without any exogenous tag to rapidly isolate intact native lysosomes from clinical samples (PBMCs from blood) and iPSC-derived neurons, enabling multimodal omics analysis of lysosomal content. |
Tagless immunoprecipitation of endogenous TMEM192, mass spectrometry-based metabolomics and proteomics of isolated lysosomes, validation in CLN3 patient samples |
The Journal of clinical investigation |
High |
39724071
|
| 2025 |
TBK1 phosphorylates FBXO3, facilitating FBXO3 interaction with TMEM192 and promoting TMEM192 ubiquitination; ubiquitinated TMEM192 is then recognized by the autophagy receptor TAX1BP1, driving lysophagic flux. Disruption of this TBK1-SCFFBXO3-TMEM192-TAX1BP1 axis reduces lysophagic flux and causes accumulation of damaged lysosomes. |
Kinase activity assay (TBK1 phosphorylation of FBXO3), co-immunoprecipitation (FBXO3-TMEM192 interaction), ubiquitination assay, autophagy flux measurement, loss-of-function perturbation |
Autophagy |
Medium |
40083080
|